{"title":"An Unusual Metastatic Pattern of a Transverse Colon Cancer: A Case Report and Review of Literature","authors":"T. Ejaz","doi":"10.19080/OAJS.2019.10.555785","DOIUrl":null,"url":null,"abstract":"Colorectal cancer (CRC) is the second most common cancer in females and the third in males worldwide [1]. The literature reported a steady increase in the incidence of CRC among both males and females under the age of 50 at a rate of 2.1% per year from 1992 through 2012 [2]. Nevertheless, screening is not currently recommended for individuals under the age of 50 unless they have inflammatory bowel disease, a positive family history, or a predisposing inherited syndrome [3]. CRCs spread principally through lymphatic and hematogenous routes, and less commonly by contiguous and trans-peritoneal dissemination [2]. Approximately 20% of patients in the United States have a distant metastatic disease at the time of presentation [2]. The most common reported metastatic sites are the liver, lungs, brain, peritoneum, and bones [2]. Most CRCs (60%) eventually develop metastatic disease, with liver involvement alone accounts for almost 50% of systemic metastasis [4].","PeriodicalId":118049,"journal":{"name":"Open Access Journal of Surgery","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Access Journal of Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19080/OAJS.2019.10.555785","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Colorectal cancer (CRC) is the second most common cancer in females and the third in males worldwide [1]. The literature reported a steady increase in the incidence of CRC among both males and females under the age of 50 at a rate of 2.1% per year from 1992 through 2012 [2]. Nevertheless, screening is not currently recommended for individuals under the age of 50 unless they have inflammatory bowel disease, a positive family history, or a predisposing inherited syndrome [3]. CRCs spread principally through lymphatic and hematogenous routes, and less commonly by contiguous and trans-peritoneal dissemination [2]. Approximately 20% of patients in the United States have a distant metastatic disease at the time of presentation [2]. The most common reported metastatic sites are the liver, lungs, brain, peritoneum, and bones [2]. Most CRCs (60%) eventually develop metastatic disease, with liver involvement alone accounts for almost 50% of systemic metastasis [4].